3 Emerging-Market Drug Maker, Chemicals Holding Group and Insecticide Brand Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, Godrej Industries and Godrej Consumer Products
- October 16, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Lincoln Pharma Rs 555.00, P/E 11.64. Godrej Industries Rs 1,030.50, P/E 15.29. Godrej Consumer Rs 869.40, P/E 46.25. Closing prices of 14 Oct 2026.
Quick Answer
Emerging-market drug maker, chemicals holding group and insecticide brand stocks with the clearest long-term roadmaps today include Lincoln Pharma in formulations sold in India and emerging export markets, Godrej Industries in chemicals, along with stakes in listed group companies in real estate, consumer products and agri-business, and a finance arm and Godrej Consumer in household insecticides, soaps and hair colour sold in India, Indonesia and Africa. FY26 revenue growth was 9.1% at Lincoln Pharma, 18.5% at Godrej Industries and 7.9% at Godrej Consumer. P/E stands at 11.64 for Lincoln Pharma (industry 37.59), 15.29 for Godrej Industries (industry 36.60) and 46.25 for Godrej Consumer (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.
Emerging-market drug maker, chemicals holding group and insecticide brand stocks give investors exposure to medicines, group businesses and household products used every day. Volumes, pricing and margins decide how much of that demand turns into profit.
This list covers three emerging-market drug maker, chemicals holding group and insecticide brand stocks: Lincoln Pharmaceuticals for formulations sold in India and emerging export markets, Godrej Industries for chemicals, along with stakes in listed group companies in real estate, consumer products and agri-business, and a finance arm and Godrej Consumer Products for household insecticides, soaps and hair colour sold in India, Indonesia and Africa. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Emerging-Market Drug Maker, Chemicals Holding Group and Insecticide Brand Stocks?
Emerging-market drug maker, chemicals holding group and insecticide brand stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.
Emerging-Market Drug Maker, Chemicals Holding Group and Insecticide Brand Stocks at a Glance
The table compares size, valuation, return on equity and debt for the three emerging-market drug maker, chemicals holding group and insecticide brand stocks as of the 14 Oct 2026 close.
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE |
|---|---|---|---|---|---|
| Lincoln Pharmaceuticals | 555.00 | 1,123 | 11.64 | 37.59 | 11.60% |
| Godrej Industries | 1,030.50 | 33,784 | 15.29 | 36.60 | 11.10% |
| Godrej Consumer Products | 869.40 | 88,506 | 46.25 | 34.85 | 14.71% |
Among healthcare, chemicals and consumer stocks, Godrej Consumer trades at a premium to the industry P/E, while Lincoln Pharma and Godrej Industries trade at a discount.
Why Do Emerging-Market Drug Maker, Chemicals Holding Group and Insecticide Brand Stocks Have a Strong Roadmap in India?
Emerging-market drug maker, chemicals holding group and insecticide brand stocks have a strong roadmap in India because export formulation demand, diversified group earnings and household brand spending keep adding volumes for these firms. Three drivers stand out.
- Formulation exports: Emerging markets buy affordable medicines.
- Group strength: Chemicals and listed stakes spread earnings across sectors.
- Household brands: Insecticides, soaps and hair colour sell across markets.
Lincoln Pharmaceuticals: Formulations for India and Export Markets Build the Next Leg
Lincoln Pharma’s roadmap rests on formulations sold in India and emerging export markets, with a broad product list supporting revenue.
Revenue grew from Rs 482.12 crore in FY22 to Rs 704.48 crore in FY26, a 46.1% rise, and FY26 revenue was 9.1% higher than FY25. FY26 net profit rose 6.7% to Rs 87.89 crore. Over four years, net profit rose from Rs 69.36 crore in FY22 to Rs 87.89 crore. In Q1 FY27, revenue grew 19.0% to Rs 201.54 crore, and net profit rose 30.9% to Rs 36.23 crore.
Debt to equity is 0.01 and return on equity is 11.60%. The dividend yield is 0.32%. At a P/E of 11.64 against an industry P/E of 37.59, the stock trades below its industry multiple.
What to watch: The P/E of 11.64 against an industry P/E of 37.59 leaves valuation less stretched, so the next quarters’ growth is the figure to follow.
Godrej Industries: Chemicals and Group Holdings Build the Next Leg
Godrej Industries’ roadmap rests on chemicals, along with stakes in listed group companies in real estate, consumer products and agri-business, and a finance arm, with its chemical business and holdings in other group companies widening the earnings base.
Revenue grew from Rs 15,064.67 crore in FY22 to Rs 25,980.60 crore in FY26, a 72.5% rise, and FY26 revenue was 18.5% higher than FY25. FY26 net profit rose 29.8% to Rs 2,411.91 crore. Over four years, net profit rose from Rs 992.43 crore in FY22 to Rs 2,411.91 crore. In Q1 FY27, revenue grew 11.2% to Rs 6,360.30 crore. Operating margin was 26.91% in FY26.
Return on equity is 11.10%. At a P/E of 15.29 against an industry P/E of 36.60, the stock trades below its industry multiple.
What to watch: The P/E of 15.29 against an industry P/E of 36.60 leaves valuation less stretched, so the next quarters’ growth is the figure to follow.
Godrej Consumer Products: Household and Personal Care Brands Drive the Pipeline
Godrej Consumer’s roadmap rests on household insecticides, soaps and hair colour sold in India, Indonesia and Africa, with a multi-country brand portfolio supporting sales.
Revenue grew from Rs 12,366.21 crore in FY22 to Rs 15,444.07 crore in FY26, a 24.9% rise, and FY26 revenue was 7.9% higher than FY25. FY26 net profit was Rs 1,861.47 crore. In Q1 FY27, revenue grew 14.2% to Rs 4,277.35 crore, and net profit rose 11.5% to Rs 504.52 crore. Operating margin was 19.45% in FY26.
Debt to equity is 0.35 and return on equity is 14.71%. FY26 operating cash flow was Rs 2,488.47 crore against capital expenditure of Rs 569.53 crore. Godrej Consumer paid a dividend of Rs 20 per share for FY26, a yield of 2.31%. At a P/E of 46.25 against an industry P/E of 34.85, the stock trades above its industry multiple.
What to watch: The P/E of 46.25 sits above the industry P/E of 34.85, so earnings delivery matters for the valuation.
Best Emerging-Market Drug Maker, Chemicals Holding Group and Insecticide Brand Stocks in India: Lincoln Pharma vs Godrej Industries vs Godrej Consumer on Key Financials
Among the best emerging-market drug maker, chemicals holding group and insecticide brand stocks in India, Lincoln Pharma leads on Q1 FY27 revenue growth and the lowest P/E; Godrej Industries leads on FY26 revenue growth; Godrej Consumer leads on return on equity and dividend yield. The table puts the numbers side by side.
| Metric | Lincoln Pharma | Godrej Industries | Godrej Consumer |
|---|---|---|---|
| FY26 revenue (Rs Cr) | 704.48 | 25,980.60 | 15,444.07 |
| FY26 revenue growth | 9.1% | 18.5% | 7.9% |
| FY26 net profit (Rs Cr) | 87.89 | 2,411.91 | 1,861.47 |
| Q1 FY27 revenue growth (YoY) | 19.0% | 11.2% | 14.2% |
| Return on equity | 11.60% | 11.10% | 14.71% |
| P/E ratio | 11.64 | 15.29 | 46.25 |
| Dividend yield | 0.32% | 0.00% | 2.31% |
Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.
How to Evaluate Emerging-Market Drug Maker, Chemicals Holding Group and Insecticide Brand Stocks to Buy Before You Invest
A short checklist keeps the research consistent when you screen emerging-market drug maker, chemicals holding group and insecticide brand stocks and shortlist emerging-market drug maker, chemicals holding group and insecticide brand stocks to buy.
- Compare each stock’s P/E with its industry P/E, which differs by company here.
- Check revenue growth, operating margin and cash flow together.
- Check whether revenue growth is turning into profit growth, not only sales.
- Read operating cash flow against capital expenditure to see how growth is funded.
- Watch debt to equity and interest cover before sizing a position.
- Spread exposure across companies and business lines instead of one demand cycle.
Risks to Consider Before Investing in Emerging-Market Drug Maker, Chemicals Holding Group and Insecticide Brand Stocks
- Consumer demand: Spending patterns can shift sales between quarters.
- Input costs: Changes in raw material prices can affect margins.
- Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.
Download the Univest iOS App or Univest Android App to track Lincoln Pharma, Godrej Industries and Godrej Consumer live.
Final Take: Which Stock Has the Strongest Roadmap?
These three healthcare, chemicals and consumer stocks cover formulations, a diversified group and household brands. Lincoln Pharma leads on Q1 FY27 revenue growth and the lowest P/E; Godrej Industries leads on FY26 revenue growth; Godrej Consumer leads on return on equity and dividend yield.
Across emerging-market drug maker, chemicals holding group and insecticide brand stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the emerging-market drug maker, chemicals holding group and insecticide brand stocks to buy discussed here.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Emerging-Market Drug Maker, Chemicals Holding Group and Insecticide Brand Stocks
Which are the best emerging-market drug maker, chemicals holding group and insecticide brand stocks in India with a strong roadmap?
Ans. Lincoln Pharmaceuticals, Godrej Industries and Godrej Consumer Products stand out for their roadmaps in formulations, a diversified group and household brands. FY26 revenue growth was 9.1% at Lincoln Pharma, 18.5% at Godrej Industries and 7.9% at Godrej Consumer, and return on equity ranges from 11.10% to 14.71%.
Is Lincoln Pharmaceuticals a good stock to buy now?
Ans. Lincoln Pharmaceuticals has a debt to equity ratio of 0.01, a return on equity of 11.60% and a P/E of 11.64 against an industry P/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.
What is the P/E ratio of Lincoln Pharma, Godrej Industries and Godrej Consumer?
Ans. The P/E ratio is 11.64 for Lincoln Pharma (industry 37.59), 15.29 for Godrej Industries (industry 36.60) and 46.25 for Godrej Consumer (industry 34.85). Only Godrej Consumer trades at or above the industry multiple.
Which of these emerging-market drug maker, chemicals holding group and insecticide brand stocks has the highest return on equity?
Ans. Godrej Consumer Products has the highest return on equity at 14.71%, followed by Lincoln Pharmaceuticals at 11.60% and Godrej Industries at 11.10%.
What are the risks of investing in emerging-market drug maker, chemicals holding group and insecticide brand stocks?
Ans. The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.
How did Lincoln Pharma, Godrej Industries and Godrej Consumer perform in Q1 FY27?
Ans. Lincoln Pharmaceuticals reported revenue of Rs 201.54 crore, up 19.0% year on year, and net profit rose 30.9% to Rs 36.23 crore. Godrej Industries reported revenue of Rs 6,360.30 crore, up 11.2% year on year. Godrej Consumer Products reported revenue of Rs 4,277.35 crore, up 14.2% year on year, and net profit rose 11.5% to Rs 504.52 crore.
Do emerging-market drug maker, chemicals holding group and insecticide brand stocks pay dividends?
Ans. Lincoln Pharma and Godrej Consumer pay dividends. The dividend yield is 0.32% for Lincoln Pharma and 2.31% for Godrej Consumer, based on dividends declared for FY26.
How can I invest in emerging-market drug maker, chemicals holding group and insecticide brand stocks in India?
Ans. You can buy emerging-market drug maker, chemicals holding group and insecticide brand stocks through a demat and trading account on NSE or BSE after checking each company’s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.